Notably, in tumor-targeted therapy, both curcumin and a novel dimanganese complex (FMSP) have been observed to downregulate CXCR4, thereby promoting the generation of ROS and inhibiting the activation of the STAT3 pathway [120,121]. The gene discussed is STAT3; the disease is neoplasm.